ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹31 Cr | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹5.23 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹96 Cr |
| Mar2021 | ₹269 Cr |
How is Net Cash Inflow / Outflow of ASTRAZENECA PHARMA INDIA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 484.51 | |
| Mar2024 | ₹5.23 Cr | -89.93 | |
| Mar2023 | ₹52 Cr | -45.96 | |
| Mar2022 | ₹96 Cr | -64.26 | |
| Mar2021 | ₹269 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹20,744.8 Cr | 3% | -2.9% | -5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 3% |
-2.9% |
-5.8% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses